Frederick W. Gluck, Director at CytomX Therapeutics, Inc. (CTMX), sold 10,000 shares at $24.27 ($243K) on 2017-10-04, disclosed to the SEC on 2017-10-06.
Open-market sale of $243k CTMX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| CTMX | SELL | 2018-03-02 | $115K | — | Filing → |
| CTMX | SELL | 2018-01-08 | $500K | — | Filing → |
| CTMX | SELL | 2017-12-28 | $111K | — | Filing → |